The effect of the administration of human gamma globulins in a model of BCG infection in mice

Tuberculosis

Volumn 86, Issue 3-4 SPEC. ISS., 2006, Pages 268-272

  Olivares, Nesty ^a   León, Annette ^a   López, Yamilé ^a   Puig, Alina ^a   Cádiz, Armando ^a   Falero, Gustavo ^a   Martínez, Máximo ^a   Sarmiento, Maria E ^a   Fariñas, Mildrey ^a   Infante, Juan F ^a   Sierra, Gustavo ^a   Solís, Rosa L ^a   Acosta, Armando ^a  

^a FINLAY INSTITUTE   (Cuba)

Author keywords

Antibodies; BCG; Infection model; Tuberculosis

Indexed keywords

IMMUNOGLOBULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CONTROLLED STUDY; DISEASE CONTROL; DRUG EFFECT; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; SALIVA;

ADMINISTRATION, INTRANASAL; ANIMALS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GAMMA-GLOBULINS; HUMANS; INFUSIONS, PARENTERAL; LUNG; MALE; MICE; MICE, INBRED BALB C; MYCOBACTERIUM BOVIS; PHAGOCYTOSIS; SALIVA; TUBERCULOSIS;

EID: 33747887158     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2006.01.006     Document Type: Article

References (21)

1. Cooper A.M., and Flynn J.A. The protective immune response to Mycobacterium tuberculosis. Curr Opin Immun 7 (1995) 512-516
2. Young D.B. Current tuberculosis vaccine development. Clin Infect Dis 30 Suppl 3 (2000) 5254-5256
3. Andersen P. Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis. Scand J Immunol 45 (1997) 115-131
4. Glatman-Freedman A., and Casadevall A. Serum therapy for tuberculosis revisited reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis. Clin Microbiol Rev 11 (1998) 514-532
5. Glatman-Freedman A. Advances in antibody-mediated immunity against Mycobacterium tuberculosis: implications for a novel vaccine strategy. FEEMS Immunol Med Microbiol 39 (2003) 9-16
6. Norazmi M.N., Sarmiento M., and Acosta A. Recent Advances in tuberculosis vaccine development. Curr Resp Med Rev 1 (2005) 109-116
7. Roy E., Stavropoulos E., Brennan J., Coade S., Grigorieva E., Walker B., et al. Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium tuberculosis infection in mice. Infect Immun 73 (2005) 6101-6109
8. de Valliere S., Abate G., Blazevic A., Heuertz R.M., and Hoft D.F. Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies. Infect Immun 73 (2005) 6711-6720
9. Guide for the use of Laboratory Animals. EEC Council Directive 86/609, OJL 358,1, December 12, 1987.
10. Cadiz A., Joo L., Moya A., and Hernandez J. Modifications of the Cohn's method of alcoholic fractionment for production of immunoglobulins. Vaccimonitor 5 (1998) 5-9
11. Falero G., Challacombe S., Rhaman D., Mistry M., Dougan G., Acosta A., et al. Transmission of IgA and IgG monoclonal antibodies to mucosal fluids following intranasal or parenteral delivery. Int Arch Allergy Immunol 122 (2000) 143-150
12. Teitelbaum R., Glatman-Freedman A., Chen B., Robbins J.B., Unanue E., Casadevall A., et al. A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proc Natl Acad Sci USA 95 (1998) 15688-15693
13. Zitrin C.M., and Wasz-Hockert O. Preliminary experiment on passive transfer of protective humoral antibodies in tuberculosis. Am Rev Tuberc Pulm Dis 76 (1957) 256-262
14. Igietseme J.U., Eko F.O., He Q., and Black C.M. Antibody regulation of T cell immunity: implications for vaccine strategies against intracellular pathogens. Expert Rev Vaccines 3 (2004) 23-34
15. Pethe K., Alonso S., Biet F., Delogu G., Brennan M.J., Locht C., et al. The heparin-binding hemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. Nature 412 (2001) 190-194
16. Mazanec M.B., Kaetzel C.S., Lam M.E., and Fletcher D. Intra-cellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci USA 89 (1992) 6901-6905
17. Mineo J.R., Khan I.A., and Kassper L.H. Toxoplasma gondii: a monoclonal antibody that inhibit intracellular replication. Exp Parasitol 79 (1994) 351-361
18. Saanford J.E., Lupan D.M., Schlageter A.M., and Kozel T.R. Passive immunization against Cryptococcus neoformans with an isotype-swich family of monoclonal antibodies reactive with criptoccocal polysaccharide. Infect Immun 58 (1990) 1919-1923
19. Choudbury A.N., Mistry F., and Antia N.H. Blocking of Mycobacterium leprae adherence to dissociated schwann cells by anti-mycobacterial antibodies. Scand J Immunol 30 (1989) 505-509
20. Band H., Sinha S., and Talwar G.P. Inhibition of interaction of mycobacteria with schwann cells by antimycobacterial antibodies. J Neuroimmunol 14 (1987) 235-239
21. Schlesinger L.S., Hull S.R., and Kaufman M. Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterim tuberculosis to human macrophages. J Immunol 152 (1994) 4070-4079